Background: Despite its physiological significance, the structural basis of desensitization in Cys-loop receptors is unknown. Results: Fluorescent reporters attached to residues at the interface of the glycine receptor ligandbinding and transmembrane domains indicate that activation and desensitization induce distinct local conformational changes.
abundance of information about the molecular rearrangements mediating channel opening (3) (4) (5) (6) (7) .
Ligand-gated channels also display a phenomenon termed desensitization, which is the progressive fading of the ionic flux in the prolonged presence of agonist. The rates of onset and recovery from desensitization are important parameters governing the size and decay rate of synaptic currents (8, 9) . As one example of the pathological importance of this mechanism, human hereditary mutations that change the rates of onset and recovery from desensitization in GABA A Rs and nAChRs have been shown to be associated with different forms of epilepsy (10, 11) . Despite the physiological and pathological importance of desensitization in Cys-loop receptors, little is known about the conformational changes that mediate this process.
According to allosteric receptor theory, ligands stabilize the states for which they display the highest affinity (12) . Thus, receptor activation occurs because agonists exhibit a higher affinity for the activated (open) than for the resting (closed) state. Similarly, desensitization occurs because agonists exhibit a higher affinity for the desensitized state than for the activated (open) state. If desensitization alters ligand affinity, then this process must involve a change in structure at the binding site. In addition, desensitization also involves a conformational change that closes the channel. Indeed, the structural basis of this closing mechanism has been elucidated in members of the structurally-distinct ionotropic glutamate receptor family (13) (14) (15) (16) . Although the M2 domains of the nAChR are known to adopt a different closed state structure in the desensitized state relative to the resting closed state (17, 18) , there is as yet no model to describe how the structure of the LBD changes during desensitization in any Cys-loop receptor. Site-directed mutations in the LBD do have effects on receptor desensitization rates (10, (19) (20) (21) (22) (23) (24) (25) (26) , supporting the idea that desensitization-specific conformational changes may occur in this region. However, the fact that mutant receptors exhibit altered desensitization rates 'does not necessarily prove that the mutated sites are structural motifs responsible for this process' (8) . Although Bouzat and colleagues (21) employed a chimeric approach to delimit the LDB-TMD interfacial region as a major determinant of Cys-loop receptor desensitization, a more direct method is required to determine whether desensitization-specific conformational changes do indeed occur in this, or any other, region of the LBD.
In the present study we employed voltage clamp fluorometry (VCF) in an attempt to systematically map LBD conformational changes that move with a similar time course to the desensitization rate as an initial step towards developing a structural model for this mechanism. VCF correlates ion flux rates with conformational changes occurring in real-time in receptor domains of interest (27, 28) . It takes advantage of the fact that changes in the quantum efficiency of certain fluorophores occur in response to changes in their immediate chemical microenvironment. Homomeric α1 GlyRs are a useful model system to study this mechanism for two reasons. First, wild type (WT) α1 GlyRs desensitize slowly (29, 30) and sitedirected mutations can be introduced at defined intracellular sites to dramatically enhance their desensitization rate (29, 31) . Second, we have previously identified numerous residues throughout the LBD, first transmembrane (M1) domain and external M2-M3 domains of α1 GlyRs that each respond with a robust glycine-induced fluorescence change (ΔF) following labeling with environmentally sensitive fluorophores (32) (33) (34) . Here we sought to compare time-dependent fluorescent changes from labels attached to 14 LBD and TMD sites in the absence of fast desensitization with those observed at the same labeled sites after an intracellular mutation had been introduced to dramatically enhance the desensitization rate. This enabled us to distinguish those conformational changes that remain unchanged throughout the period of ligand-binding from those that tracked the desensitization rate. Although we found no evidence for conformational changes associated with desensitization at any of the labeled sites near the glycine-binding site, we did identify desensitizationspecific conformational changes in loop 2 and the pre-M1 domain, which are both structural components of the LBD-TMD interface.
EXPERIMENTAL PROCEDURES
Reagents used in VCF ExperimentsSulforhodamine methanethiosulfonate (MTS-R) and 2-((5(6)-tetramethylrhodamine) carboxylamino)ethyl methanethiosulfonate (MTS-TAMRA) were purchased from Toronto Research Chemicals (North York, ON). Alexa Fluor 546 C 5 maleimide (AF546) and tetramethylrhodamine-6-maleimide (TMRM) were purchased from Invitrogen (Carlsbad, CA). MTS-R, MTS-TAMRA and TMRM were dissolved in dimethyl sulfoxide (DMSO) and stored at -20°C. AF546 was dissolved directly into ND96 solution (96 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , 5 mM HEPES) on the day of the experiment and stored on ice for up to 6 hr. Glycine stocks were dissolved in ND96 and stored at -20°C. Molecular Biology -The rat α1 GlyR subunit cDNA was subcloned into the pGEMHE expression vector. The wild type (WT) and all mutant constructs incorporated the C41A mutation to eliminate the 3 sole uncrosslinked extracellular cysteine. QuickChange (Stratagene, La Jolla, CA) was used to generate all cysteine mutants used in this study. The successful incorporation of the mutations was confirmed by the automated sequencing of the entire coding sequence. Capped mRNA for oocyte injection was generated using mMessage mMachine (Ambion, Austin, TX). Oocyte Preparation, Injection and LabelingOocytes from Xenopus laevis (Xenopus Express, France) were prepared as described previously (32) and injected with 10 ng mRNA. The oocytes were then incubated at 18 °C for 3-7 days in a solution containing 96 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , 5 mM HEPES, 0.6 mM theophylline, 2.5 mM pyruvic acid, 50 µg/ml gentamycin (Cambrex Corporation, East Rutherford, NJ), pH 7.4. On the day of recording, oocytes were transferred into ND96 containing 10-20 µM of fluorophore. Typical labeling times were 30 s for MTS-R and MTS-TAMRA (on ice), 30 min for TMRM (on ice) or 45 min for AF546 (at room temperature). Oocytes were then washed thoroughly and stored in ND96 on ice for up to 6 hr before recording. All fluorophores employed here respond with an increase in quantum efficiency as the hydrophobicity of their environment is increased (27, 33) . Each cysteine mutant was incubated with all four fluorophores in turn and generally the one yielding the largest glycine-induced ΔF was analysed. As unmutated GlyRs never exhibited a ΔF or a change in electrophysiological properties following fluorophore incubation, we rule the possibility of labels binding nonspecifically to receptors. VCF and Data Analysis -The experimental set up comprized an inverted fluorescence microscope (IX51, Olympus, Tokyo, Japan) equipped with a high-Q tetramethylrhodamine isothiocyanate filter set (Chroma Technology, Rockingham, VT), a LUCPlanFLN 40x/NA0.6 objective (Olympus), and a PhotoMax 200 photodiode (Dagan Corporation, Minneapolis, MN) with a 12 V/100 W halogen lamp (Olympus) as light source. The recording chamber is similar to those described previously (35, 36) . Cells were voltage-clamped at -40 mV and currents were recorded with an OC-725C oocyte amplifier (Warner, Hamden, CT). Current and fluorescence traces were acquired at 200 Hz via a Digidata 1322A interface using pClamp 9.2 software (Axon Instruments, Union City, CA). Fluorescence signals were digitally filtered at 1-2 Hz with an eight-pole Bessel filter for analysis and display. Half-maximal concentrations (EC 50 ) and Hill coefficient (n H ) values for ligand-induced activation of current and fluorescence were obtained using the Hill equation, fitted with a non-linear least squares algorithm (SigmaPlot 9.0, Systat Software, Point Richmond, CA). All results are expressed as mean ± S.E.M. of three or more independent experiments. Unless otherwise indicated, statistical analysis was performed using unpaired Student's t-test, with p < 0.05 representing significance.
RESULTS
WT α1 GlyR currents exhibit a low rate of desensitization with a ΔI time constant (τΔI) that typically exceeds 25 s (29) . However, the A248L mutation in the intracellular M1-M2 loop increases τΔI to around 1 s (29) . We have previously identified a range of cysteine-substituted residues in the LBD and pre-M1 domains of α1 GlyRs that, when tagged with an environmentally sensitive fluorophore, elicit robust glycine-induced ΔF responses (32) (33) (34) . Here we sought to compare the time course of the ΔI and ΔF responses of each of these cysteine-substituted receptors with and without the desensitization-enhancing A248L mutation. We reasoned that fluorescence signals that increase or decrease in magnitude with a ΔF time constant (τΔF) comparable with τΔI are likely to be reporting a conformational change associated with desensitization. Alternately, those ΔF signals that remain constant during desensitization are more likely to be reporting a conformational change associated with agonist-binding or receptor activation.
Mean glycine EC 50 , n H and ΔI max values for the A248L mutant GlyR are summarized in Table 1 . We found the glycine EC 50 value was increased by around an order of magnitude relative to the WT value. We also found the ΔI max decayed rapidly and almost completely, with a τΔI of 1.53 ± 0.13 s (n=4).
We then investigated the following mutations located in either agonist binding domains or extracellular agonist transduction domains: H201C and N203C in binding domain loop C, Q67C in binding domain loop D, S121C and L127C in binding domain loop E, G181C and G221C in binding domain loop F, E217C, Q219C, G221C in the pre-M1 domain, M227C in the M1 domain, A52C in loop 2, K143C in the conserved Cys-loop (or loop 7) and R271C in the M2-M3 domain. Unfortunately, four of the double mutant receptors were not suitable for investigation. The S121C-A248L and L127C-A248L mutant GlyRs exhibited extremely low glycine sensitivities such that 300 mM glycine activated non-desensitizing currents, the E217C-A248L mutant GlyR did not produce a detectable ΔF with any of the four tested fluorophores and the R271C-A248L mutant GlyR did not express at all. The remaining nine mutant GlyRs all exhibited robust glycine-activated ΔI and ΔF responses when expressed either as single mutants or as double mutants with A248L. The τΔI values for all double mutant GlyRs in response to a saturating (EC 200 ) glycine are comparable with the value observed at the A248L mutant GlyR ( Table 2) .
The standard experimental approach applied to all cysteine-substituted GlyRs is illustrated in the example for the G181C mutant GlyR in Fig. 1 . This mutation is located in loop F which lines the base of the glycine binding pocket. First, we quantitated the ΔI and ΔF concentration-response relationships in the MTS-R-labeled G181C-A248L GlyR. A sample concentration-response is shown in Fig. 1A and averaged results are plotted in Fig. 1B . The mean glycine EC 50 and n H values of best fit to individual concentration-response relationships are summarized in Table 1 . The corresponding values for the MTS-R-labeled G181C GlyR have been published previously (33) . In the labeled double mutant, the glycine ΔI EC 50 value (5.4 ± 0.4 mM) is significantly higher (P < 0.05) than the corresponding ΔF EC 50 value (1.7 ± 0.2 mM). The corresponding values in the single mutant were reversed, with mean values of 39.8 ± 1.8 µM for ΔI and 508 ± 65 µM for ΔF (33) . It is evident from Fig.  1A that ΔI desensitized rapidly whereas ΔF did not. This is particularly evident when responses are compared with those of the single mutant MTS-Rlabeled G181C GlyR at a saturating glycine concentration (Fig. 1C) . To compare the decay rates of the ΔI and ΔF signals in both mutants, we expressed averaged signal magnitudes at 20 s following commencement of the glycine application as a percentage of their respective maximum values. We then normalized the averaged ΔI/ΔI max and ΔF/ΔF max data for the G181C GlyR to a value of one, and applied the same normalization factor to the respective responses observed at the G181C-A248L GlyR. The averaged results, shown in Fig. 1D , confirm that the ΔI/ΔI max ratio declined significantly in the double mutant GlyR whereas the ΔF/ΔF max ratio did not. We thus conclude the fluorophore covalently attached to G181C does not detect a conformational change associated with desensitization.
The Q67C, H201C, N203C and G221C mutant GlyRs all responded in a similar manner to the G181C mutant GlyR. The fluorescent labels employed at each receptor are the same as used previously (33) and are listed in Table 1 . Sample ΔI max and ΔF max responses for each labeled single and double mutated receptor are shown in Fig. 2A with averaged 20 s ΔI/ΔI max and ΔF/ΔF max values shown in Fig. 2B . It is evident that ΔF does not report a conformational change associated with desensitization in any of these mutants. The ΔI max , ΔF max values, together with the glycine EC 50 and n H values of best fit to ΔI and ΔF concentrationresponse curves, for all displayed double mutant constructs are summarized in Table 1 , whereas the corresponding values for the single mutant constructs have previously been published (33) . Together, the results presented in Figs. 1 and 2 indicate that we were not able to detect conformational changes associated with desensitization at any tested location near the glycine-binding site.
A52 is located in loop 2, a domain that has long been implicated in conformational changes associated with receptor opening (3-7) . The MTS-TAMRA-labeled A52C mutant GlyR elicits a robust glycine-induced ΔF which is thought to report a conformational change associated with the transition from the resting closed state to the glycine-bound pre-open (or flip) state (34) . Sample ΔF max and ΔI max responses from MTS-TAMRA-labeled A52C and A52C-A248L mutant GlyRs are shown in Fig. 3A . The τΔI and τΔF values at the double mutant receptor were both significantly reduced relative to those observed at the single mutant receptor, but were not significantly different from each other (Fig.  3B) . The glycine concentration-response at the A52C-A248L mutant GlyRs revealed a complex ΔF waveform (Fig. 3C) . At low (0.1 -0.3 mM) glycine concentrations, there is little evidence of desensitization in either the ΔI or ΔF responses. At glycine concentrations ≥1 mM, the decay rate of both ΔI and ΔF became progressively faster as glycine concentration was increased. This ΔF signal decayed to a plateau level that became progressively higher as glycine concentration was increased. A third feature, apparent only at desensitizing glycine concentrations, is the appearance of a transient increase in ΔF upon glycine removal. The averaged concentration-response relationships for the 'glycine-on' peak, the plateau and the 'glycine-off' peak confirm these trends (Fig. 3D) . It was not possible to reliably generate ΔF EC 50 values from these results. Given the result of Fig. 3B , we quantitated the τΔI and τΔF values for glycine concentrations ≥ 1 mM by fitting the initial (i.e., 'glycine-on') decay phase with a single exponential. The results, plotted in Fig. 3E , confirm that there is no significant difference between average τΔI and τΔF values at any glycine concentration, consistent with the ΔF response reporting a conformational change associated with desensitization.
We next sought to determine whether the decay phase of the 'glycine-off' ΔF response may report a conformational change associated with recovery from desensitization. As a first step, we quantitated the ΔI recovery from desensitization time course by applying paired 5 s applications of saturating (30 mM) glycine separated by increasing time intervals. The averaged results, summarized in Fig. 3F , exhibited a half-recovery time of 9.4 ± 1.7 s (n=5). The averaged half-decay time of the glycineoff ΔF signal, averaged from 6 cells at 30 mM glycine, was 10.9 ± 3.2 s. These values are not significantly different (p=0.70 by unpaired t-test), strongly suggesting that the glycine-off ΔF response at the A52C-A248L mutant GlyR reported a conformational change associated with recovery from desensitization.
M227 is located in the M1 domain. We have previously shown that the AF546-labeled M227C mutant GlyR exhibits a glycine-induced ΔF decrease (33) . A comparison of the effects of a saturating glycine concentration on ΔI max and ΔF max in the AF546-labeled M227C and M227C-A248L mutant GlyRs is shown in Fig. 4A . The complex ΔF max waveform in the double mutant receptor is reminiscent of that observed in Fig. 3A . The τΔI and τΔF values at the double mutant receptor were both significantly faster than those observed at the single mutant receptor, but were not significantly different from each other (Fig. 4B) . The sample ΔI and ΔF glycine concentration-response relationship for the M227C-A248L mutant GlyR, shown in Fig. 4C , reveals a very similar ΔF glycine concentrationresponse profile as observed for the A52C-A248L mutant GlyR (Fig. 3C) . To strengthen the case that this ΔF reports a conformational change associated with desensitization, we quantitated the τΔI and τΔF values for glycine concentrations ≥ 1 mM by fitting the initial (glycine-on) decay phase with a single exponential. The results, plotted in Fig. 4D , confirm that there is no significant difference between τΔI and τΔF values at any glycine concentration, consistent with the interpretation that an AF546 fluorophore attached to M227C reports a conformational change associated with desensitization. We compared the decay phase of the glycine-off ΔF response with the ΔI recovery from desensitization time course as described above for the A52C-A248L mutant GlyR. As shown in Fig.  4E , the ΔI exhibited a half-recovery time of 10.5 ± 0.8 s (n=4), whereas the averaged half-decay time of the glycine-off ΔF signal was 15.5 ± 1.0 s (n=5). Although these values are significantly different (P<0.05 by unpaired t-test), their magnitudes are sufficiently close to each other as to suggest that the glycine-off ΔF response reports a conformational change associated with recovery from desensitization.
Q219C is located in the pre-M1 domain which connects the LBD and TMD regions. We previously showed that the MTS-R-labeled Q219C mutant GlyR exhibits a glycine-induced decrease in ΔF (33) . The comparison of ΔI max and ΔF max responses in MTS-R-labeled Q219C and Q219C-A248L mutant GlyRs in Fig. 5A shows the expected increase in τΔI in the double mutant receptor. This figure also reveals a slowly-developing ΔF in the Q219C GlyR and a more rapidly-developing ΔF in the Q219C-A248L GlyR. The averaged 20 s ΔI/ΔI max ratios confirmed the expected decrease in τΔI in the double mutant receptor (Fig. 5B) . The Q219C mutation itself increases the τΔI from >25 s in the WT GlyR to 8.1 ± 1.0 s (n=4) in the labeled Q219C mutant GlyR. It appears in Fig. 5A and B that the onset of the ΔF response parallels the ΔI decay rate in both the single and double mutant receptors. We therefore hypothesized that the ΔF signal in both the Fig. 5C , demonstrate that the ΔI and ΔF τ values are indistinguishable from each other at each of the tested glycine concentrations. We then performed the same test on the double mutant GlyR. A sample glycine concentrationresponse for both ΔI and ΔF is shown in Fig. 5D , with the respective averaged τ values shown in Fig.  5E . The correspondence between ΔF rise τ values and ΔI decay τ values is strong, but significantly different at low glycine concentrations.
The averaged ΔI recovery from desensitization time courses for the labeled Q219C and Q219C-A248L GlyRs are shown in Fig. 5F and G, respectively. The labeled Q219C GlyR exhibited a ΔI half-recovery time of 22.7 ± 2.2 s (n=3), whereas the corresponding ΔF half-decay time was 23.6 ± 1.7 s (n=6), These results are not significantly different from each other (P=0.76). Similar results were obtained for the double mutant GlyR, where the mean ΔI and ΔF half-recovery times were 17.9 ± 1.5 s (n=4) and 14.0 ± 1.3 s (n=5), respectively. These values are also not significantly different to each other (P = 0.11). Together, all these results suggest that the ΔF signals in both the MTS-Rlabeled Q219C and Q219C-A248L mutant GlyRs report conformational changes associated with the onset and recovery from desensitization.
We have so far demonstrated conformational changes associated with the onset and recovery from desensitization in the pre-M1, M1 and β1−β2 loop domains. These domains, located at the interface betweeen the LBD and TMD, are important for transmitting the agonist binding signal to the gate. In an attempt to refine our understanding of the desensitization conformational changes occurring in this region, we attempted to label further residues in the loop 2 (from E51C -D56C) but were not successful. Because the conserved Cysloop interacts closely with both loop 2 and the pre-M1 domains and is also important in the channel activation process (3-7), we then attempted to label cysteine-substituted residues between P140 and D148 in this domain. When the K143C mutant GlyR was labeled with MTS-R, it produced mean glycineinduced ΔI max and ΔF max values of 1.8 ± 0.2 µA and 1.9 ± 0.1 % (both n=4). The ΔI and ΔF glycine concentration-response parameters of best fit for the unlabeled and MTS-R-labeled K143C mutant GlyRs are summarized in Table 1 . The ΔF glycine concentration-response parameters of best fit for the MTS-R-labeled K143C mutant GlyRs are also summarized in Table 1 . The corresponding parameters for the unlabeled and MTS-R-labeled double mutant K143C-A248L GlyR are also summarized in Table 1 . In contrast with the labeled K143C mutant GlyR, the ΔF EC 50 value is significantly lower than the corresponding ΔI EC 50 value. Although the τΔI of the double mutant GlyR exhibited the expected rapid desensitization rate (Table 2) , the ΔF response showed no significant change over the 20 s period following glycine application, remaining at 97 ± 3 % (n=4) of original magnitude. Thus, we conclude that the conformational change reported by the label attached to K143C is not related to desensitization. However, this does not necessarily mean that the Cys-loop does not experience a desensitizationspecific structural change.
DISCUSSION

General considerations for data interpretation
Recombinant α1 GlyRs do not desensitize rapidly and the mutation we introduced to enhance desensitization may have introduced structural changes unlike those occurring during 'real' fast desensitization in nAChRs or GABA A Rs. However, the converse experimental approach suffers from a similar limitation. That is, if mutations are introduced to eliminate desensitization in naturally fast-desensitizing Cys-loop receptors, the question arises as to whether all conformational changes associated with desensitization have been removed and the native activation mechanism has been faithfully restored. The problem with simply quantitating ΔF responses in naturally fastdesensitizing Cys-loop receptors is that it becomes difficult to differentiate those ΔFs that respond to desensitization only from those that respond to both desensitization and activation. If multiple structural mechanisms of desensitization do exist among members of the Cys-loop receptor family, then it is possible that native mechanism may vary from receptor to receptor. We therefore acknowledge that the mechanism of desensitization investigated here may not be universally applicable throughout the receptor family.
We have recently discussed the limitations of VCF for interpreting conformational changes in agonist-gated ion channels (28, 33, 37, 38) . Briefly, a ligand-induced ΔF implies that the microenvironment of an attached fluorophore has been altered via a direct fluorophore-ligand interaction, a ligand-induced conformational change associated with channel opening and/or a ligandinduced conformational change associated with a mechanism (e.g., desensitization) unrelated to channel opening. It is often difficult to discriminate among these mechanisms. However, by comparing τΔF and τΔI values in slow-and fast-desensitizing mutants that incorporate labels attached to the same site, we can isolate those ΔF responses that occur in response to desensitzation. Furthermore, as desensitization-specific ΔF signals observed here were observed at sites distant from the ligandbinding site, we can eliminate direct fluorophoreligand interactions.
Due to the difficulty in effecting rapid solution exchange around oocytes, we are not able to reliably resolve τΔI or τΔF values faster than about 1 s. It is therefore possible we may have missed extremely fast desensitization events in some mutants. This does not, however, impact on the conclusions of this study. Finally, as a conformational change can occur without producing a fluorophore microenvironmental change, the absence of a ΔF component that tracks the desensitization rate does not necessarily mean that a local desensitization-specific structural change has not occurred.
Conformational changes reported by labels attached to A52C and M227C
Loop 2 is well-established as a crucial element of the Cys-loop receptor activation machinery (3-7). We previously found that the ΔF max of a label attached to A52C in this domain is correlated with agonist efficacy, suggesting that it reports conformation change associated with the agonist-induced closed-flip state transition (34) . In the fast-desensitizing A52C-A248L mutant GlyR, we propose that the net glycine-mediated ΔF response represents the sum of those ΔFs corresponding to activation and desensitization. In particular, we suggest that glycine-binding induces a stepwise decrease in ΔF similar to that observed in the labeled single mutant A52C GlyR, and that this component of the ΔF signal reverses completely when glycine unbinds. When this stepwise signal is subtracted from the net ΔF waveform, we are left with a ΔF of opposite polarity that we hypothesize reports a conformational change associated with desensitization only. The on-phase of this signal has the same τΔF as the ΔI desensitization rate and the off-phase has the same half-recovery time as ΔI. Our interpretation is supported by the observation that the initial negative ΔF max (shown as filled circles in Fig. 3D ) is not significantly different to the step increase in ΔF seen upon glycine removal (shown as the difference between triangles and unfilled circles in Fig. 3D) .
We further suggest that the net ΔF signal reported by the label attached to the M227C-A248L mutant GlyR can be interpreted in exactly the same way. It is intriguing that the ΔF plateau signal (represented by unfilled circles in Fig. 3D ) at both A52C-A248L and M227C-A248L mutants tends towards increasingly positive ΔF values as glycine concentration is increased. This implies that the ΔF due to desensitization is still increasing at glycine concentrations where the ΔF due to activation has reached a maximum. This is expected since fast desensitization generally only becomes prominent at high agonist EC values. The non-zero ΔF plateau level indicates that the conformational changes due to desensitization and activation are not equal and opposite to each other. If they were, then the net ΔF plateau response should asymptote towards zero at high glycine concentrations when the saturating current desensitized completely. We thus conclude that activation and desensitization are mediated by physically distinct conformational changes in loop 2 and the M1 domain.
Conformational changes reported by a label attached to Q219C
Relative to the WT GlyR, the Q219C mutant GlyR exhibits an enhanced desensitization rate. This is consistent with previous studies showing that the desensitization rate is critically dependent on the identity of corresponding residues in the pre-M1 domain of GlyRs (22) and other Cys-loop receptors (19, 21) . We conclude that a label attached to the Q219C mutant GlyR reports a conformational change associated with desensitization because the ΔF on-and off-rates tracked the ΔI desensitization and recovery rates, respectively, in both the slowdesensitizing Q219C mutant GlyR and the fastdesensitizing Q219C-A248L mutant GlyR.
A role for these conformational changes in desensitization
To summarize, we have observed desensitization-specific conformational changes in the vicinity of A52 in loop 2, Q219 in the pre-M1 domain and M227 in the outer part of M1. In muscle nAChRs and homomeric ρ1 GABA A Rs it has been shown that a direct electrostatic interaction exists in the closed state between loop 2 and pre-M1 domain residues that correspond to E53 and R218 in the α1 GlyR (39,40,41) . In the muscle nAChR it was shown that channel activation perturbed this salt bridge (41), although a follow-up study found that this perturbation was unlikely to play a major role in gating (42) . Irrespective of the precise movements and mechanisms involved in activation, these results suggest a close physical association between loop 2 and the pre-M1 domain which in turn implies that desensitization could simply involve an alteration in their relative orientations. However, it is likely that other interfacial domains are also involved in desensitization conformational changes. An agonistmediated perturbation at this interface is likely to realign all interfacial domains (i.e., the M2-M3 loop, the pre-M1 domain and LBD loops 2, 7 and 9) inducing the breakage and reformation of numerous bonds (43) , leading ultimately to a reconfiguration of the M2-M3 loop and the opening of the channel. The novel insight provided by the present study is that desensitization involves conformational changes in the interfacial region that are distinct from those involved in activation or deactivation. Such conformational changes would be expected to prevent the activation-triggering molecular realignments from taking place and would thus maintain the channel in the closed state. Our demonstration of desensitization-specific conformational changes at the interfacial and M1 domains explains the results of a recent chimeric study that implicated loop 2, the conserved Cys-loop and the outer part of M1 as the main elements responsible for the difference in desensitization rates between slow-and fast-desensitizing Cys-loop receptors (21) . They also explain the results of sitedirected mutagenesis studies that had previously implicated loop 2 and pre-M1 domain residues as structural determinants of Cys-loop receptor desensitization (19, 22, 26, 44) .
Conclusion
We employed VCF to directly demonstrate that GlyR activation and desensitization are accompanied by physically distinct conformational changes at the interface between the LBD and the TMD. Since activation is mediated by a specific reorganisation of molecular interactions at this interface, we propose that desensitization is mediated by a distinct set of conformational changes that is incompatible with activation, and thereby closes the channel. Thus, the locations of the desensitization-specific conformational changes reported here imply that they mediate, rather than occur in response to, desensitization. Averaged ΔF glycine concentration-response relationship at labeled A52C-A248L mutant GlyRs. As indicated in the inset, the initial negative peak is plotted using filled circles, the glycine-induced plateau is plotted using unfilled circles and the peak of the positive glycine-off response is plotted using triangles. All points were averaged from 4 cells. 
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